6 research outputs found
MOESM1 of A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants
Additional file 1. K13 bMx prototype assay 5-step workflow (24 DBS in less than 4Â h)
MOESM7 of A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants
Additional file 7. Clinical performances of the K13 reference assay obtained from 65 DBS collected from P. falciparum asymptomatic individuals in Cambodia. Cells coloured in green present concordant data obtained between the K13 bMx prototype assay and the K13 reference assay; Cells coloured in pale red present discordant data obtained between the K13 bMx prototype assay and the K13 reference assay
MOESM5 of A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants
Additional file 5. Overall clinical performances of the K13 reference assay obtained from 642 DBS collected from P. falciparum symptomatic patients in Cambodia, Myanmar and Africa and P. falciparum asymptomatic individuals in Cambodia. Cells coloured in green present concordant data obtained between the K13 bMx prototype assay and the K13 reference assay; Cells coloured in pale red present discordant data obtained between the K13 bMx prototype assay and the K13 reference assay
Description of variants observed but unknown in MITOMAP.
<p>Pos.: position on mitochondrial genome</p><p>Ref.: Reference allele</p><p>Alt.: Alternative allele</p><p>Description of variants observed but unknown in MITOMAP.</p
Description of variants predicted as deleterious by SIFT and as probably damaging by Polyphen.
<p>Ref.: Reference allele</p><p>Alt.: Alternative allele</p><p>Freq.: Minor allele frequency observed in our data</p><p>a. a. change: amino acid change</p><p>Description of variants predicted as deleterious by SIFT and as probably damaging by Polyphen.</p
Inclusion categories of selected index cases.
<p>Inclusion categories of selected index cases.</p